Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McMaster University

$120,000.00

Synergistic Targeting of Glioblastoma Using VSVJuninG-IL-15-CD133 Oncolytic Virus and CD133-Specific CAR-T Cells

EF 2025-26

Résumé
Immunotherapy is a new type of cancer treatment where scientist train the patient's immune cells to fight against the cancer. This is done by making the immune cells target specific markers called "proteins" on the surface of the cancer cell to kill them. However, a large obstacle for this new treatment is that cancer cells hide these markers making it hard for the trained immune cells locate and kill them. Another problem is that after a period of time, the trained immune cells get tired and no longer work. Scientists are currently working on ways to make these trained immune cells better at fighting against cancer. For my PhD project, I am using a special virus called "oncolytic virus" that only infect cancer cells. Once they are inside the cancer cell, this virus takes over the cancer cell's machinery and makes them show the markers that the immune cells are trained to look for. This helps trained the immune cells to recognize and destroy the cancer more easily. Another way that this "oncolytic virus" helps with this new cancer treatment is by sending out a signal that helps to "wake up" the tired trained immune cells to keep them in the fight. This signal is called "IL-15" and it is something that the natural immune systems already make to keep them working against infections. My goal is to create a new treatment that can help boost the immune system of patients with cancer to fight off these tricky cancer cells. Doing this will help to improve outcomes for patients facing cancer.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
559311
Name
Topley Max F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Synergistic Targeting of Glioblastoma Using VSVJuninG-IL-15-CD133 Oncolytic Virus and CD133-Specific CAR-T Cells
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cancer Cell Biology; Cancer Stem Cell; Glioblastoma; Immunotherapy; Oncolytic Virus; Patient Derived Cell Lines; Patient Derived Xenograft; Preclinical Translational Research
Abstract
Immunotherapy is a new type of cancer treatment where scientist train the patient's immune cells to fight against the cancer. This is done by making the immune cells target specific markers called "proteins" on the surface of the cancer cell to kill them. However, a large obstacle for this new treatment is that cancer cells hide these markers making it hard for the trained immune cells locate and kill them. Another problem is that after a period of time, the trained immune cells get tired and no longer work. Scientists are currently working on ways to make these trained immune cells better at fighting against cancer. For my PhD project, I am using a special virus called "oncolytic virus" that only infect cancer cells. Once they are inside the cancer cell, this virus takes over the cancer cell's machinery and makes them show the markers that the immune cells are trained to look for. This helps trained the immune cells to recognize and destroy the cancer more easily. Another way that this "oncolytic virus" helps with this new cancer treatment is by sending out a signal that helps to "wake up" the tired trained immune cells to keep them in the fight. This signal is called "IL-15" and it is something that the natural immune systems already make to keep them working against infections. My goal is to create a new treatment that can help boost the immune system of patients with cancer to fight off these tricky cancer cells. Doing this will help to improve outcomes for patients facing cancer.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Topley, Max F
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~